Issue 3, 2020

An investigation of the polymorphism of a potent nonsteroidal anti-inflammatory drug flunixin

Abstract

Flunixin [2-(3-trifluoromethyl-2-methyl-phenylamino)-nicotinic acid, FLX], a potent nonsteroidal anti-inflammatory drug widely used in veterinary medicine, was found to exist in at least two crystal forms (I and II), in contrast to clonixin [2-(3-chloro-2-methyl-phenylamino)-nicotinic acid, CLX], which exists in four solvent-free forms and multiple solvates. Form I was harvested from a variety of solvents and characterized by single-crystal X-ray diffraction, PXRD, FT-IR, and Raman spectroscopy. Its crystal structure is sustained on the strong acid–pyridine hydrogen bond. Form II was generated by thermal treatment of form I. Other aspects of this polymorphic system were investigated both experimentally and theoretically. Quantum chemistry calculations were performed to shed light on the lack of polymorphism from solution-phase crystallization. Conformational scan of the dihedral angle C2–N7–C8–C9 (τ) revealed two stable conformations, one with τ near 170°, and the other near 70°, corresponding to the molecule in the crystal. Hirshfeld analysis accounted for the major intermolecular interactions contributing to the overall stability of the crystal.

Graphical abstract: An investigation of the polymorphism of a potent nonsteroidal anti-inflammatory drug flunixin

Supplementary files

Article information

Article type
Paper
Submitted
14 Oct 2019
Accepted
22 Nov 2019
First published
24 Nov 2019

CrystEngComm, 2020,22, 448-457

Author version available

An investigation of the polymorphism of a potent nonsteroidal anti-inflammatory drug flunixin

H. Liu, X. Yang, S. Wu, M. Zhang, S. Parkin, S. Cao, T. Li, F. Yu and S. Long, CrystEngComm, 2020, 22, 448 DOI: 10.1039/C9CE01619H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements